First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex

These data demonstrate that first-line treatment with tivozanib was associated with clinical activity, favorable tolerability, and stable QoL in patients with mRCC treated in everyday clinical practice across Germany, including those with advanced age.

Authors

Institutions

Publication Details

Journal
Cancers
Published
2025-12-07
DOI
https://doi.org/10.3390/cancers17243910
Primary Topic
Renal cell carcinoma treatment
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex

Viktor Grünwald, Claus Fieseler, Christian Doehn, Carsten Lange et al.
Cancers
Renal cell carcinoma treatment
article

First-Line Treatment with Tivozanib for Metastatic Renal Cell Carcinoma in Real-World Settings Across Germany: Results of the Prospective, Non-Interventional, Post-Approval Study T-Rex

Viktor Grünwald, Claus Fieseler, Christian Doehn, Carsten Lange, Philipp Ivanyi, Silke Schirrmacher-Memmel, Andreas Janitzky, Norbert Marschner, Horst Brenneis, Eva Hellmis, S. Seseke, Diana Standhaft, B Loehr, Steffen Baumann, O. Rau, Carsten Ziske, Andrea Distelrath, Martin Bögemann, Karen Rußwurm, Michael Seidel, Ralf Eckert, Miriam Hegemann, Martin Herold
article en

Abstract

These data demonstrate that first-line treatment with tivozanib was associated with clinical activity, favorable tolerability, and stable QoL in patients with mRCC treated in everyday clinical practice across Germany, including those with advanced age.

CancersVol. 17(24)
American Urological Association (US), ZF Friedrichshafen (Germany) (DE), University Medical Center Freiburg (DE), Steinbeis Foundation (DE), Medizinische Hochschule Hannover (DE), Städtisches Klinikum Dessau (DE), Halle Zoo (DE), Klinikum Aschaffenburg (DE), University Hospital Münster (DE), Recordati (Ireland) (IE), Essen University Hospital (DE), University Hospital Leipzig (DE), Prüf- und Forschungsinstitut Pirmasens (Germany) (DE), University Hospital Magdeburg (DE), BG Klinikum Duisburg (DE), Klinikum Sindelfingen-Böblingen (DE), Institut für Automatisierung und Informatik (DE), University Hospital in Halle (DE), St. Bonifatius Hospital (DE), Aschaffenburg University of Applied Sciences (DE), Rehazentrum Wilhelmshaven (DE), Atos Medical (DE), Klinikum Wilhelmshaven (DE), Leipzig University (DE), University of Lübeck (DE)
Openalex Percentile: Top 43%
Renal cell carcinoma treatment
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.